Table 3.
The number of cases by summary stage
| The number of cases in 2020 | The number of cases during 2018–2019 (average) | Difference in the cases | Proportionate difference | |
|---|---|---|---|---|
| Stomach cancer | ||||
| Stage I | 45 356 | 53 570 | −8214 | -15.3 |
| Stage II | 6061 | 7040 | −979 | -13.9 |
| Stage III | 7176 | 7907 | −731 | -9.2 |
| Stage IV | 13 753 | 14 606 | −853 | -5.8 |
| Colon cancer | ||||
| Stage 0 | 31 105 | 34 108 | −3003 | -8.8 |
| Stage I | 22 611 | 24 037 | −1426 | -5.9 |
| Stage II | 22 251 | 23 328 | −1077 | -4.6 |
| Stage III | 22 009 | 22 972 | −963 | -4.2 |
| Stage IV | 17 753 | 17 826 | −73 | -0.4 |
| Hepatocellular carcinoma | ||||
| Stage I | 8813 | 9263 | −450 | -4.9 |
| Stage II | 4511 | 4965 | −454 | -9.1 |
| Stage III | 2814 | 3028 | −214 | -7.1 |
| Stage IV | 1680 | 1657 | 23 | 1.4 |
| Intrahepatic cholangiocarcinoma | ||||
| Stage I | 562 | 594 | −32 | -5.4 |
| Stage II | 699 | 786 | −87 | -11.1 |
| Stage III | 735 | 707 | 28 | 4.0 |
| Stage IV | 1453 | 1380 | 73 | 5.3 |
| Small cell lung cancer | ||||
| Stage I | 600 | 582 | 18 | 3.1 |
| Stage II | 521 | 553 | −32 | -5.8 |
| Stage III | 2012 | 2124 | −112 | -5.3 |
| Stage IV | 4445 | 4633 | −188 | -4.1 |
| Non-small cell lung cancer | ||||
| Stage 0 | 3087 | 3357 | −270 | -8.0 |
| Stage I | 32 488 | 32 929 | −441 | -1.3 |
| Stage II | 6668 | 7122 | −454 | -6.4 |
| Stage III | 12 914 | 13 297 | −383 | -2.9 |
| Stage IV | 24 497 | 24 679 | −182 | -0.7 |
| Breast cancer | ||||
| Stage 0 | 9834 | 10 222 | −388 | -3.8 |
| Stage I | 30 332 | 31 532 | −1200 | -3.8 |
| Stage II | 22 165 | 22 737 | −572 | -2.5 |
| Stage III | 7516 | 7519 | −3 | 0.0 |
| Stage IV | 4295 | 4065 | 230 | 5.7 |
| Oesophageal cancer | ||||
| Stage 0 | 2615 | 2860 | −245 | -8.6 |
| Stage I | 8460 | 9105 | −645 | -7.1 |
| Stage II | 2334 | 2597 | −263 | -10.1 |
| Stage III | 3196 | 3226 | −30 | -0.9 |
| Stage IV | 4897 | 4999 | −102 | -2.0 |
| Pancreatic cancer | ||||
| Stage 0 | 742 | 722 | 20 | 2.8 |
| Stage I | 6044 | 4777 | 1267 | 26.5 |
| Stage II | 4093 | 4361 | −268 | -6.1 |
| Stage III | 1822 | 1704 | 118 | 6.9 |
| Stage IV | 12 350 | 12 314 | 36 | 0.3 |
| Prostate cancer | ||||
| Stage I | 19 031 | 21 128 | −2097 | -9.9 |
| Stage II | 15 991 | 16 982 | −991 | -5.8 |
| Stage III | 9233 | 9804 | −571 | -5.8 |
| Stage IV | 10 162 | 10 111 | 51 | 0.5 |
| Cervical cancer | ||||
| Stage 0 | 18 175 | 19 414 | −1239 | -6.4 |
| Stage I | 3552 | 3867 | −315 | -8.1 |
| Stage II | 1397 | 1466 | −69 | -4.7 |
| Stage III | 2338 | 2379 | −41 | -1.7 |
| Stage IV | 1289 | 1266 | 23 | 1.8 |
| Endometrial cancer | ||||
| Stage I | 10 312 | 9999 | 313 | 3.1 |
| Stage II | 827 | 777 | 50 | 6.4 |
| Stage III | 1863 | 1864 | −1 | -0.1 |
| Stage IV | 1333 | 1295 | 38 | 2.9 |
| Bladder cancer | ||||
| Stage 0 | 14 464 | 14 760 | −296 | -2.0 |
| Stage I | 7378 | 7399 | −21 | -0.3 |
| Stage II | 3350 | 3148 | 202 | 6.4 |
| Stage III | 2353 | 2249 | 104 | 4.6 |
| Stage IV | 1044 | 918 | 126 | 13.7 |
| Laryngeal cancer | ||||
| Stage 0 | 285 | 346 | −61 | -17.6 |
| Stage I | 1620 | 1908 | −288 | -15.1 |
| Stage II | 906 | 971 | −65 | -6.7 |
| Stage III | 645 | 674 | −29 | -4.3 |
| Stage IV | 810 | 839 | −29 | -3.5 |
| Gallbladder cancer | ||||
| Stage 0 | 298 | 259 | 39 | 15.1 |
| Stage I | 481 | 537 | −56 | -10.4 |
| Stage II | 754 | 835 | −81 | -9.7 |
| Stage III | 968 | 1034 | −66 | -6.4 |
| Stage IV | 2201 | 2311 | −110 | -4.8 |
| Kidney cancer | ||||
| Stage I | 10 465 | 10 813 | −348 | -3.2 |
| Stage II | 660 | 638 | 22 | 3.4 |
| Stage III | 1770 | 1814 | −44 | -2.4 |
| Stage IV | 1872 | 1739 | 133 | 7.6 |
| Renal pelvis and ureter cancer | ||||
| Stage 0 | 1507 | 1395 | 112 | 8.0 |
| Stage I | 1153 | 1099 | 54 | 4.9 |
| Stage II | 892 | 884 | 8 | 0.9 |
| Stage III | 1682 | 1662 | 20 | 1.2 |
| Stage IV | 2056 | 2066 | −10 | -0.5 |
| Ovarian cancer | ||||
| Stage I | 5597 | 5653 | −56 | -1.0 |
| Stage II | 789 | 837 | −48 | -5.7 |
| Stage III | 2986 | 2960 | 26 | 0.9 |
| Stage IV | 1849 | 1781 | 68 | 3.8 |